Globe Life Inc. GL
We take great care to ensure that the data presented and summarized in this overview for GLOBE LIFE INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding GL
View all-
Vanguard Group Inc Valley Forge, PA10.4MShares$1.29 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.1MShares$756 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.93MShares$488 Million0.09% of portfolio
-
State Street Corp Boston, MA3.5MShares$433 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA2.61MShares$324 Million0.02% of portfolio
-
Morgan Stanley New York, NY1.83MShares$227 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.59MShares$197 Million0.04% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA1.28MShares$159 Million0.12% of portfolio
-
Nuance Investments, LLC Kansas City, MO1.23MShares$153 Million6.31% of portfolio
-
Norges Bank Oslo, Q81.01MShares$125 Million0.02% of portfolio
Latest Institutional Activity in GL
Top Purchases
Top Sells
About GL
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
Insider Transactions at GL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Mar 19
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,750
-47.5%
|
$346,500
$126.41 P/Share
|
|
Mar 19
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,750
+32.2%
|
$283,250
$103.23 P/Share
|
|
Mar 04
2025
|
Robert Edward Hensley EVP & Chief Investment Officer |
SELL
Open market or private sale
|
Direct |
1,610
-13.64%
|
$199,640
$124.81 P/Share
|
|
Mar 03
2025
|
Philip M Jacobs Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+50.0%
|
-
|
|
Mar 03
2025
|
Matthew J Adams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+50.0%
|
-
|
|
Feb 28
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,220
+28.64%
|
-
|
|
Feb 28
2025
|
Rebecca E Zorn EVP & Chief Talent Officer |
BUY
Grant, award, or other acquisition
|
Direct |
980
+6.7%
|
-
|
|
Feb 28
2025
|
Dolores L Skarjune EVP and Chief Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,205
+12.82%
|
-
|
|
Feb 28
2025
|
Christopher Kyle Tyler EVP and Chief Info Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,125
+17.66%
|
-
|
|
Feb 28
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,686
+11.0%
|
-
|
|
Feb 28
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
BUY
Grant, award, or other acquisition
|
Direct |
1,310
+13.96%
|
-
|
|
Feb 28
2025
|
Michael Clay Majors EVP - Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,385
+2.86%
|
-
|
|
Feb 28
2025
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,055
+5.69%
|
-
|
|
Feb 28
2025
|
Robert Edward Hensley EVP & Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,290
+9.85%
|
-
|
|
Feb 28
2025
|
James Matthew Darden Co-Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,686
+6.89%
|
-
|
|
Feb 26
2025
|
Rebecca E Zorn EVP & Chief Talent Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,746
-12.11%
|
$211,266
$121.93 P/Share
|
|
Feb 26
2025
|
Rebecca E Zorn EVP & Chief Talent Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,307
+23.01%
|
-
|
|
Feb 26
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,662
-15.14%
|
$564,102
$121.93 P/Share
|
|
Feb 26
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,845
+27.78%
|
-
|
|
Feb 26
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,755
-28.94%
|
$333,355
$121.93 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 93K shares |
|---|---|
| Exercise of conversion of derivative security | 144K shares |
| Open market or private purchase | 14K shares |
| Bona fide gift | 330 shares |
| Discretionary transaction | 2.58K shares |
| Open market or private sale | 144K shares |
|---|---|
| Payment of exercise price or tax liability | 23.9K shares |
| Bona fide gift | 772 shares |